LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 2 | J08 | 72 | hr | 962 | 6880 | 10507 | 0.6548 | 0.7689 |
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 3 | J08 | 72 | hr | 962 | 6697 | 10315 | 0.6492 | 0.7629 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 1 | J07 | 72 | hr | 962 | 3652 | 10714 | 0.3409 | 0.4676 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 2 | J07 | 72 | hr | 962 | 3496 | 10507 | 0.3327 | 0.4536 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 3 | J07 | 72 | hr | 962 | 3439 | 10315 | 0.3334 | 0.4509 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 1 | H12 | 72 | hr | 962 | 7738 | 10693 | 0.7236 | 0.8222 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 2 | H12 | 72 | hr | 962 | 7463 | 10740 | 0.6948 | 0.8014 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 3 | H12 | 72 | hr | 962 | 8403 | 10641 | 0.7896 | 0.8683 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 962 | 5679 | 10693 | 0.5311 | 0.6669 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 962 | 5090 | 10740 | 0.4739 | 0.6138 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 962 | 6088 | 10641 | 0.5721 | 0.7025 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 962 | 3002 | 10693 | 0.2807 | 0.3875 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 962 | 3839 | 10740 | 0.3574 | 0.4882 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 962 | 3710 | 10641 | 0.3486 | 0.4759 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 1 | H09 | 72 | hr | 962 | 2144 | 10693 | 0.2005 | 0.2594 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 2 | H09 | 72 | hr | 962 | 2025 | 10740 | 0.1885 | 0.2384 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 3 | H09 | 72 | hr | 962 | 2409 | 10641 | 0.2264 | 0.3030 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 1 | H08 | 72 | hr | 962 | 1419 | 10693 | 0.1327 | 0.1183 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 2 | H08 | 72 | hr | 962 | 1487 | 10740 | 0.1384 | 0.1332 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 3 | H08 | 72 | hr | 962 | 1621 | 10641 | 0.1523 | 0.1623 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 1 | H07 | 72 | hr | 962 | 212 | 10693 | 0.0198 | -0.3530 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 2 | H07 | 72 | hr | 962 | 193 | 10740 | 0.0180 | -0.3697 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 3 | H07 | 72 | hr | 962 | 219 | 10641 | 0.0206 | -0.3475 |
MCF 10A | NVP-AEW541 | 0.04 | uM | LJP5 | 1 | E18 | 72 | hr | 962 | 10766 | 10714 | 1.0049 | 1.0028 |
MCF 10A | NVP-AEW541 | 0.04 | uM | LJP5 | 2 | E18 | 72 | hr | 962 | 10556 | 10507 | 1.0046 | 1.0027 |